Lineage Cell Therapeutics, Inc. · AMEX:LCTX
BlackRock, Inc.'s stake in Lineage Cell Therapeutics, Inc. fell to 4.60% (Schedule 13G/A)
Event Dec 31, 2024 · Filed Feb 5, 2025
BlackRock, Inc.'s stake in Lineage Cell Therapeutics, Inc. fell to 4.60%, 10,094,677 shares, as a passive investor on Dec 31, 2024. Filed Feb 5, 2025 (Schedule 13G/A).
- Stake
- 4.60%
- Shares
- 10,094,677
- Intent
- Passive
- What changed
- Fell below 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BlackRock, Inc. | 4.60% | 10,094,677 |
Source
Related
- Lineage Cell Therapeutics, Inc.
- BlackRock, Inc.
- Lineage Cell Therapeutics, Inc. shareholders
- Schedule 13G · BlackRock, Inc. · Jul 29, 2026
- Schedule 13G/A · BlackRock, Inc. · Jul 17, 2025
- Schedule 13G · BlackRock, Inc. · Apr 24, 2025
- Schedule 13D/A · Neal C. Bradsher · Nov 14, 2025
- Schedule 13G · Chernett Jorey · Sep 26, 2025
- Schedule 13D/A · Neal C. Bradsher · Jan 28, 2025